4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-24-066177
Chief Operating Officer sold 7,910 shares at $74.31 ($587,813)
- Chief Operating Officer acquired 13,693 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…